About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5477 record(s)
Req # A-2019-001800
Adverse Reaction Report (AER) for POLYSPORIN. Report numbers: 000003047, 000014656, 000144085, 000319887, 000430437, 000661650, 000697934, 000708285. AER for IMODIUM / LOPERAMIDE HCI. Report numbers: 000698619, 000166886,000223788, 000373375, 000680312, 000688067, 000689740, 000727463. AER for ROGAINE. Report numbers: 000058921, 000070668, 000078274, 000154562, 000700961, 000709320, 000718463. AER for MOTRIMAX. Report numbers: 000671220, 000680949, 000715106.Organization: Health Canada
February 2020
Req # A-2019-001808
Adverse Reaction Report (AER). Report number: 000731953.Organization: Health Canada
February 2020
Req # A-2019-001818
Adverse Reaction Report (AER). Report number: 000730360.Organization: Health Canada
February 2020
Req # A-2019-001819
Adverse Reaction Report (AER). Report number: E2B_02805620.Organization: Health Canada
February 2020
Req # A-2019-001846
Adverse Reaction Report (AER). Report number: E2B_02796708.Organization: Health Canada
February 2020
Req # A-2019-001872
Adverse Reaction Report (AER). Report number: E2B_02770421.Organization: Health Canada
February 2020
Nothing to report this month
Organization: Federal Bridge Corporation
Req # A-2014-000300
All records related to the use of antibiotics in livestock and to antimicrobial resistance from January 1, 2012 to March 20, 2015.Organization: Health Canada
January 2020
Req # A-2015-000481
All copies of Domestic Adverse Reaction Reports where Tofacitinib/Xeljanz (Drug Identification Number (DIN): 02423898) is identified as the primary suspect drug from January 1. 2005-December 31, 2015.Organization: Health Canada
January 2020
Req # A-2015-000494
All records related to a meeting of the Working Group on Articles 9 and 10 of the World Health Organization Framework Convention on Tobacco Control held in Turkey in February 2016, including Mr. Denis Choiniere and Mr. Matthew Cook.Organization: Health Canada
January 2020